Dishman Carbogen Amcis Ltd

Dishman Carbogen Amicis is engaged in the process of research and development to late-stage clinical and commercial manufacturing.

Pros:
Stock is trading at 0.67 times its book value
Cons:
Though the company is reporting repeated profits, it is not paying out dividend
Company might be capitalizing the interest cost

Peer Comparison Sector: Pharmaceuticals // Industry: Pharmaceuticals - Indian - Bulk Drugs & Formln

Loading peers table ...

Quarterly Results Consolidated Figures in Rs. Crores / View Standalone

Jun 2016 Sep 2016 Dec 2016 Mar 2017 Jun 2017 Sep 2017 Dec 2017 Mar 2018 Jun 2018 Sep 2018 Dec 2018 Mar 2019
376 434 362 534 340 444 460 451 482 448 479 650
271 321 263 388 270 311 339 330 361 319 346 480
Operating Profit 105 113 99 146 70 133 121 121 121 129 133 169
OPM % 28% 26% 27% 27% 21% 30% 26% 27% 25% 29% 28% 26%
Other Income 4 13 16 4 7 9 15 16 6 15 13 20
Interest 22 20 13 10 11 13 13 11 15 15 14 13
Depreciation 51 55 51 57 51 55 55 50 54 58 58 71
Profit before tax 36 51 50 83 14 74 68 75 58 71 74 106
Tax % 16% 25% 35% 48% 6% 35% 38% 32% 32% 38% 31% 28%
Net Profit 30 38 32 43 13 48 42 51 40 44 51 76
Notes Notes Notes Notes Notes Notes Notes Notes Notes Notes Notes Notes

Profit & Loss Consolidated Figures in Rs. Crores / View Standalone

Mar 2017 Mar 2018 TTM
1,714 1,695 2,059
1,261 1,249 1,507
Operating Profit 452 445 552
OPM % 26% 26% 27%
Other Income 26 46 54
Interest 49 49 57
Depreciation 214 211 240
Profit before tax 216 231 309
Tax % 33% 33%
Net Profit 145 155 211
EPS in Rs 9.58
Dividend Payout % 0% 0%
* Sales is net of excise duty and discounts
Compounded Sales Growth
10 Years:%
5 Years:%
3 Years:%
TTM:21.47%
Compounded Profit Growth
10 Years:%
5 Years:%
3 Years:%
TTM:36.40%
Return on Equity
10 Years:%
5 Years:%
3 Years:%
Last Year:3.09%

Balance Sheet Consolidated Figures in Rs. Crores / View Standalone

Mar 2017 Mar 2018 Mar 2019
0 32 32
Reserves 4,814 5,075 5,347
Borrowings 950 1,095 883
1,046 1,187 1,067
Total Liabilities 6,810 7,389 7,328
4,852 5,066 5,129
CWIP 133 151 143
Investments 40 196 167
1,785 1,977 1,889
Total Assets 6,810 7,389 7,328

Cash Flows Consolidated Figures in Rs. Crores / View Standalone

Mar 2017 Mar 2018
303 226
-107 -297
-137 78
Net Cash Flow 59 7

Ratios Consolidated Figures in Rs. Crores / View Standalone

Mar 2017 Mar 2018
ROCE % 5%
Debtor Days 61 96
Inventory Turnover 3.72